Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Magnetic Resonance Disease Severity Scale (MRDSS) Predicts Clinical Progression in Multiple Sclerosis

Bakshi R, Neema M, Healy B, Liptak Z, Betensky R, Buckle G, Gauthier S, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury S, Guttmann CRG, Weiner HL . Magnetic Resonance Disease Severity Scale (MRDSS) Predicts Clinical Progression in Multiple Sclerosis. 10th Annual Meeting of the American Society for Experimental NeuroTherapeutics, Arlington, VA. 2008.


© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.